ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P06209


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name POLG_POL32
Primary accession number P06209
Secondary accession numbers None
Integrated into Swiss-Prot on January 1, 1988
Sequence was last modified on January 23, 2007 (Sequence version 3)
Annotations were last modified on    November 4, 2008 (Entry version 87)
Name and origin of the protein
Protein name Genome polyprotein
Synonyms None
Contains Protein VP0
     (VP4-VP2)
Protein VP4
     (Virion protein 4)
     (P1A)
Protein VP2
     (Virion protein 2)
     (P1B)
Protein VP3
     (Virion protein 3)
     (P1C)
Protein VP1
     (Virion protein 1)
     (P1D)
Picornain 2A
     (Protein 2A)
     (P2A)
     (EC 3.4.22.29)
Protein 2B
     (P2B)
Protein 2C
     (P2C)
     (EC 3.6.1.15)
Protein 3A
     (P3A)
Protein 3B
     (P3B)
     (VPg)
Picornain 3C
     (EC 3.4.22.28)
     (Protease 3C)
     (P3C)
RNA-directed RNA polymerase 3D-POL
     (P3D-POL)
     (EC 2.7.7.48)
Gene name None
From
Poliovirus type 3 (strain 23127) [TaxID: 12087] 
Taxonomy Viruses; ssRNA positive-strand viruses, no DNA stage; Picornavirales; Picornaviridae; Enterovirus.
Virus host Homo sapiens (Human) [TaxID: 9606]
Protein existence 3: Inferred from homology;
References
[1]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
PubMed=3020156 [NCBI, ExPASy, EBI, Israel, Japan]
Hughes P.J., Evans D.M.A., Minor P.D., Schild G.C., Almond J.W., Stanway G.;
"The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland.";
J. Gen. Virol. 67:2093-2102(1986).
Comments
  • FUNCTION: Capsid proteins VP1, VP2, VP3 and VP4 form a closed capsid enclosing the viral positive strand RNA genome. VP4 lies on the inner surface of the protein shell formed by VP1, VP2 and VP3. All the three latter proteins contain a beta-sheet structure called beta-barrel jelly roll. Together they form an icosahedral capsid (T=3) composed of 60 copies of each VP1, VP2, and VP3, with a diameter of approximately 300 Angstroms. VP1 is situated at the 12 fivefold axes, whereas VP2 and VP3 are located at the quasi-sixfold axes. The interaction of five VP1 proteins in the fivefold axes results in a prominent protusion extending to about 25 Angstroms from the capsid shell. The resulting structure appears as a steep plateau encircled by a valley or cleft. This depression also termed canyon is the receptor binding site. The capsid interacts with human PVR at this site to provide virion attachment to target cell (By similarity).
  • FUNCTION: VP0 precursor is a component of immature procapsids (By similarity).
  • FUNCTION: Protein 2A is a cysteine protease that is responsible for the cleavage between the P1 and P2 regions. It cleaves the host translation initiation factor EIF4G1, in order to shut down the capped cellular mRNA transcription (By similarity).
  • FUNCTION: Protein 2B affects membrane integrity and cause an increase in membrane permeability (By similarity).
  • FUNCTION: Protein 2C associates with and induces structural rearrangements of intracellular membranes. It displays RNA-binding, nucleotide binding and NTPase activities (By similarity).
  • FUNCTION: Protein 3A, via its hydrophobic domain, serves as membrane anchor. It also inhibits endoplasmic reticulum-to-Golgi transport (By similarity).
  • FUNCTION: Protein 3C is a cysteine protease that generates mature viral proteins from the precursor polyprotein. In addition to its proteolytic activity, it binds to viral RNA, and thus influences viral genome replication. RNA and substrate bind co-operatively to the protease (By similarity).
  • FUNCTION: RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity).
  • CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1).
  • CATALYTIC ACTIVITY: Selective cleavage of Tyr-|-Gly bond in the picornavirus polyprotein.
  • CATALYTIC ACTIVITY: Selective cleavage of Gln-|-Gly bond in the poliovirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
  • CATALYTIC ACTIVITY: NTP + H2O = NDP + phosphate.
  • SUBCELLULAR LOCATION: Protein VP2: Virion. Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: Protein VP3: Virion. Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: Protein VP1: Virion. Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: Protein 2B: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • SUBCELLULAR LOCATION: Protein 2C: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • SUBCELLULAR LOCATION: Protein 3A: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • SUBCELLULAR LOCATION: Protein 3B: Virion (Potential).
  • SUBCELLULAR LOCATION: Picornain 3C: Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: RNA-directed RNA polymerase 3D-POL: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • PTM: Specific enzymatic cleavages in vivo by the viral proteases yield a variety of precursors and mature proteins. Polyprotein processing intermediates such as VP0 which is a VP4-VP2 precursor are produced. During virion maturation, non-infectious particles are rendered infectious following cleavage of VP0. This maturation cleavage is followed by a conformational change of the particle (By similarity).
  • PTM: VPg is covalently linked to the genomic RNA (By similarity).
  • PTM: Myristoylation of VP4 is required during RNA encapsidation and formation of the mature virus particle (By similarity).
  • SIMILARITY: Belongs to the picornaviruses polyprotein family.
  • SIMILARITY: Contains 2 peptidase C3 domains [view classification].
  • SIMILARITY: Contains 1 RdRp catalytic domain.
  • SIMILARITY: Contains 1 SF3 helicase domain.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
X04468; CAA28155.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR A27245; GNNY27.
3D structure databases
HSSP Q84790; 1PVC. [HSSP ENTRY / PDB]
ModBase P06209.
Protein family/group databases
MEROPS C03.001; -.
Ontologies
GO
GO:0031410; Cellular component: cytoplasmic vesicle (inferred from electronic annotation from UniProtKB-KW).
GO:0016020; Cellular component: membrane (inferred from electronic annotation from UniProtKB-KW).
GO:0044419; Biological process: interspecies interaction between organisms (inferred from electronic annotation from UniProtKB-KW).
QuickGo view.
Family and domain databases
InterPro IPR003593; AAA+_ATPase_core.
IPR004004; Helicase/Pol/Pept_Calicivir.
IPR000605; Helicase_SF3_ssDNA/RNA_vir.
IPR014759; Helicase_SF3_ssRNA_vir.
IPR014838; P3A.
IPR000199; Pept_C3_picorn.
IPR000081; Peptidase_C3.
IPR003138; Pico_P1A.
IPR002527; Pico_P2B.
IPR001676; Picornavirus_capsid.
IPR001205; RNA_pol_P3D.
IPR007094; RNA_pol_PSvir.
Graphical view of domain structure.
Pfam PF08727; P3A; 1.
PF00548; Peptidase_C3; 1.
PF02226; Pico_P1A; 1.
PF00947; Pico_P2A; 1.
PF01552; Pico_P2B; 1.
PF00680; RdRP_1; 1.
PF00073; Rhv; 3.
PF00910; RNA_helicase; 1.
Pfam graphical view of domain structure.
PRINTS PR00918; CALICVIRUSNS.
ProDom PD001125; Pept_C3_picorn; 1.
PD001306; Peptidase_C3_2; 1.
PD001274; Pico_P2B; 1.
[Domain structure / List of seq. sharing at least 1 domain]
SMART SM00382; AAA; 1.
SMART graphical view of domain structure.
PROSITE PS50507; RDRP_SSRNA_POS; 1.
PS51218; SF3_HELICASE_2; 1.
PROSITE graphical view of domain structure (profiles).
BLOCKS P06209.
ProtoNet P06209.
Other
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
ATP-binding; Capsid protein; Complete proteome; Covalent protein-RNA linkage; Cytoplasm; Cytoplasmic vesicle; Helicase; Host-virus interaction; Hydrolase; Lipoprotein; Membrane; Myristate; Nucleotide-binding; Nucleotidyltransferase; Phosphoprotein; Protease; RNA replication; RNA-binding; RNA-directed RNA polymerase; Thiol protease; Transferase; Virion.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
INIT_MET   1      1        Removed; by host (By similarity). 
CHAIN   2    340  339     Protein VP0 (Potential). PRO_0000311082
CHAIN   2     69  68     Protein VP4 (Potential). PRO_0000040124
CHAIN   70    340  271     Protein VP2 (Potential). PRO_0000040125
CHAIN   341    578  238     Protein VP3 (Potential). PRO_0000040126
CHAIN   579    878  300     Protein VP1 (Potential). PRO_0000040127
CHAIN   879   1027  149     Picornain 2A (Potential). PRO_0000040128
CHAIN   1028   1124  97     Protein 2B (Potential). PRO_0000040129
CHAIN   1125   1453  329     Protein 2C (Potential). PRO_0000040130
CHAIN   1454   1540  87     Protein 3A (Potential). PRO_0000040131
CHAIN   1541   1562  22     Protein 3B (Potential). PRO_0000040132
CHAIN   1563   1745  183     Picornain 3C (Potential). PRO_0000040133
CHAIN   1746   2206  461     RNA-directed RNA polymerase 3D-POL (Potential). PRO_0000040134
TOPO_DOM   2   1517  1516     Cytoplasmic (Potential). 
TOPO_DOM   1518   1533  16     In membrane (Potential). 
TOPO_DOM   1534   2206  673     Cytoplasmic (Potential). 
DOMAIN   1229   1385  157     SF3 helicase. 
DOMAIN   1972   2087  116     RdRp catalytic. 
NP_BIND   1253   1260  8     ATP (Potential). 
ACT_SITE   898    898        For picornain 2A activity (By similarity). 
ACT_SITE   916    916        For picornain 2A activity (By similarity). 
ACT_SITE   987    987        For picornain 2A activity (By similarity). 
ACT_SITE   1602   1602        For picornain 3C activity (Potential). 
ACT_SITE   1633   1633        For picornain 3C activity (Potential). 
ACT_SITE   1709   1709        For picornain 3C activity (By similarity). 
SITE   69     70  2     Cleavage (Potential). 
SITE   340    341  2     Cleavage; by picornain 3C (Potential). 
SITE   878    879  2     Cleavage; by picornain 2A (Potential). 
SITE   1027   1028  2     Cleavage; by picornain 3C (Potential). 
SITE   1124   1125  2     Cleavage; by picornain 3C (Potential). 
SITE   1453   1454  2     Cleavage; by picornain 3C (Potential). 
SITE   1540   1541  2     Cleavage; by picornain 3C (Potential). 
SITE   1562   1563  2     Cleavage; by picornain 3C (Potential). 
SITE   1745   1746  2     Cleavage; by picornain 3C (Potential). 
MOD_RES   1543   1543        O-(5'-phospho-RNA)-tyrosine (By similarity). 
LIPID   2      2        N-myristoyl glycine; by host (By similarity). 
Sequence information
Length: 2206 AA [This is the length of the unprocessed precursor] Molecular weight: 245733 Da [This is the MW of the unprocessed precursor] CRC64: F226AD85403C37BA [This is a checksum on the sequence]
        10         20         30         40         50         60 
MGAQVSSQKV GAHENSNRAY GGSTINYTTI NYYKDSASNA ASKQDYSQDP SKFTEPLKDV 

        70         80         90        100        110        120 
LIKTAPALNS PNVEACGYSD RVLQLTLGNS TITTQEAANS VVAYGRWPEF IRDDEANPVD 

       130        140        150        160        170        180 
QPTEPDVATS RFYTLDTVMW GKESRGWWWK LPDALRDMGL FGQNMYYHYL GRSGYTVHVQ 

       190        200        210        220        230        240 
CNASKFHQGS LGVFAIPEFC LAGDSDTQRY TSYANANPGE KGGKFYAQFN KDTAVTSPKR 

       250        260        270        280        290        300 
EFCPVDYLLG CGVLIGNAFV FPHQIINLRT NNSATLVLPY VNALSIDSMV KHNNWGIAIL 

       310        320        330        340        350        360 
PLSPLDFAQD SSVEIPITVT IAPMCSEFNG LRNVTAPKLQ GLPVLNTPGS NQYLTSDNHQ 

       370        380        390        400        410        420 
SPCAIPEFDV TPPIDIPGEV KNVMELAEID TMIPLNLENT KRNTMDMYRV RLSDSANLSG 

       430        440        450        460        470        480 
PILCLSLSPA ADPRLSHTML GEVLNYYTHW AGSLKFTFLF CGSMMATGKL LVAYAPPGAQ 

       490        500        510        520        530        540 
PPTSRKEAML GTHVIWDLGL QSSCTMVVPW ISNVTYRQTT QDSFTEGGYI SMFYQTRIVV 

       550        560        570        580        590        600 
PLSTPKAMDM LGFVSACNDF SVRLLRDTTH ISQAAMPQGV DDLITEVAQN ALALSLPKPQ 

       610        620        630        640        650        660 
SNLPDTKASG PAHSKEVPTL TAVETGATNP LVPSDTVQTR HVIQQRSRSE STIESFFARG 

       670        680        690        700        710        720 
ACVAIIEVDN EQPATNVQKL FATWRITYKD TVQLRRKLEF FTYSRFDMEF TFVVTANFTN 

       730        740        750        760        770        780 
SNNGHALNQV YQIMYIPPGA PTPKSWDDYT WQTSSNPSIF YTYGAAPARI SVPYVGLANA 

       790        800        810        820        830        840 
YSHFYDGFAK VPLKSDANDQ VGDSLYSAMA VDDFGVLAIR VVNDHNPTKV TSKVRVYMKP 

       850        860        870        880        890        900 
KHVRVWCPRP PRAVPYYGPG VDYKDGLAPL SEKGLTTYGF GHQNKAVYTA GYKICNYHLA 

       910        920        930        940        950        960 
TQEDLQNAVS VMWNRDLLVT ESKAQGIDSI ARCNCSTGVY YCESRSRYYP VSFVGPTFQY 

       970        980        990       1000       1010       1020 
MEANDYYPAR YQSHMLIGHG FASPGDCGGI LRCQHGVIGI ITAGGEGLVA FSDIRDLYAY 

      1030       1040       1050       1060       1070       1080 
EEEAMEQGIS SYVESLGAAF GSGFTQQIGD KIIELTGMVT STITEKLLKN LIKIVSSLVI 

      1090       1100       1110       1120       1130       1140 
ITRNYDDTTT VLATLALLGC DVSPWQWLKK KACDILEIPY VMRQGDSWLK KFTEACNAAK 

      1150       1160       1170       1180       1190       1200 
GLEWVSNKIS KFIDWLREKI IPQARDKLEF VTKLKQLEML ENQIATIHQS CPSQEHQEIL 

      1210       1220       1230       1240       1250       1260 
FNNVRWLSIQ SKRFAPLYAL EAKRIQKLEH TINNYIQFKS KHRIEPVCLL VHGSPGTGKS 

      1270       1280       1290       1300       1310       1320 
VATNLIARAI AEKENTSTYS LPPDPSHFDG YKQQGVVIMD DLNQNPDGAD MKLFCQMVST 

      1330       1340       1350       1360       1370       1380 
VEFIPPMASL EEKGILFTSN YVLASTNSSR ITPPTVAHSD ALARRFAFDM DIQVMSEYSR 

      1390       1400       1410       1420       1430       1440 
DGKLNMTMAT EMCKNCHQPA NFKRCCPLVC GKAIQLMDKS SRVRYSIDQI TTMIVNEKNR 

      1450       1460       1470       1480       1490       1500 
RSNIGNCMEA LFQGPLQYKD LKIDIKTTPP PECINDLLQA VDSQEVRDYC EKKGWIVNIT 

      1510       1520       1530       1540       1550       1560 
SQVQTERNIN RAMTILQAVT TFAAVAGVVY VMYKLFAGHQ GAYTGLPNKR PNVPTIRTAK 

      1570       1580       1590       1600       1610       1620 
VQGPGFDYAV AMAKRNILTA TTSKGEFTML GVHDNVAILP THASPGETIV IDGKEIEVLD 

      1630       1640       1650       1660       1670       1680 
AKALEDQAGT NLEITIVTLK RNEKFRDIRP HIPAQITETN DGVLIVNTSK YPNMYVPVGA 

      1690       1700       1710       1720       1730       1740 
VTEQGYLNLG GRQTARTLMY NFPTRAGQCG GVITCTGKVI GMHVGGNGSH GFAAALKRSY 

      1750       1760       1770       1780       1790       1800 
FTQSQGEIQW MRPSKEVGYP IINAPSKTKL EPSAFHYVFE GVKEPAVLTK NDPRFKTGFE 

      1810       1820       1830       1840       1850       1860 
EAIFSKYVGN KITEVDEYMK EAVDHYAGQL MSLDINTEQM CLEDAMYGTD GLEALDLSTS 

      1870       1880       1890       1900       1910       1920 
AGYPYVTMGK KKRDILNKQT RDTKEMQRLL DTYGINLPLV TYVKDELRSK TKVEQGKSRL 

      1930       1940       1950       1960       1970       1980 
IEASSLNDSV AMRMAFGNLY AAFHKNPGVV TGSAVGCDPD LFWSKIPVLM EEKLFAFDYT 

      1990       2000       2010       2020       2030       2040 
GYDASLSPAW FEALKMVLEK IGFGDRVDYI DYLNHSHHLY KNKTYCVKGG MPSGCSGTSI 

      2050       2060       2070       2080       2090       2100 
FNSMINNLII RTLLLKTYKG IDLDHLKMIA YGDDVIASYP HEVDASLLAQ SGKDYGLTMT 

      2110       2120       2130       2140       2150       2160 
PADKSATFET VTWENVTFLK RFFRADERYP FLIHPVMPMK EIHESIRWTK DPRNTQDHVR 

      2170       2180       2190       2200 
SLCLLAWHNG EDEYNKFLAM IRSVPIGRAL LLPEYSTLYR RWLDSF 

P06209 in FASTA format

View entry in original UniProtKB/Swiss-Prot format
View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!